胃不全麻痺薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Gastroparesis Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8102688)・商品コード:GIR8102688
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年8月31日
・ページ数:132
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、胃不全麻痺薬の世界市場について調べ、まとめました。種類別セグメントは、消化管機能改善薬、制吐剤、ボツリヌス毒素注射、その他等、用途別セグメントは、糖尿病性胃不全麻痺、特発性胃不全麻痺等に区分しました。胃不全麻痺薬の世界市場概観、メーカー動向、メーカー別胃不全麻痺薬シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・胃不全麻痺薬の市場概観
・胃不全麻痺薬のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・胃不全麻痺薬のメーカー別販売動向、市場シェア、市場集中度、競争動向
・胃不全麻痺薬の世界市場規模
・胃不全麻痺薬の北米市場分析(アメリカ、カナダ、メキシコ等)
・胃不全麻痺薬のアメリカ市場規模推移
・胃不全麻痺薬のカナダ市場規模推移
・胃不全麻痺薬のメキシコ市場規模推移
・胃不全麻痺薬のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・胃不全麻痺薬のドイツ市場規模推移
・胃不全麻痺薬のイギリス市場規模推移
・胃不全麻痺薬のロシア市場規模推移
・胃不全麻痺薬のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・胃不全麻痺薬の日本市場規模推移
・胃不全麻痺薬の中国市場規模推移
・胃不全麻痺薬の韓国市場規模推移
・胃不全麻痺薬のインド市場規模推移
・胃不全麻痺薬の東南アジア市場規模推移
・胃不全麻痺薬の南米市場分析(ブラジル、アルゼンチン等)
・胃不全麻痺薬の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・胃不全麻痺薬の種類別分析/市場規模推移(消化管機能改善薬、制吐剤、ボツリヌス毒素注射、その他)
・胃不全麻痺薬の用途別分析/市場規模推移(糖尿病性胃不全麻痺、特発性胃不全麻痺)
・胃不全麻痺薬の市場予測(地域別予測、種類別予測、用途別予測)
・胃不全麻痺薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Gastroparesis also known as delayed gastric emptying, is a disorder that stops or slows the movement of food through the digestive tract.

Scope of the Report:

This report studies the Gastroparesis Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gastroparesis Drugs market by product type and applications/end industries.

The idiopathic gastroparesis segment dominated the global gastroparesis drugs market during 2017 and the segment is expected to continue its dominance during the next few years as well. The market is witnessing the development of new and effective therapies for the symptomatic control of idiopathic gastroparesis, which will be one of the major factors responsible for the market segment’s growth.

The prokinetic agents segment accounted for the major shares of the gastroparesis drugs market and according to this market research and analysis, the segment will continue its market dominance during the next few years as well. Prokinetic agents are used to relieve a large number of gastrointestinal (GI) symptoms such as bloating, constipation, abdominal discomfort, vomiting, nausea, and heartburn.

The global Gastroparesis Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gastroparesis Drugs.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Cadila Pharmaceuticals

GlaxoSmithKline

Johnson & Johnson

Valeant

Evoke Pharma

Teva Pharmaceutical Industries

Theravance Biopharma

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Prokinetic Agents

Antiemetic Agents

Botulinum Toxin Injection

Other

Market Segment by Applications, can be divided into

Diabetic Gastroparesis

Idiopathic Gastroparesis

【レポートの目次】

Table of Contents

1 Gastroparesis Drugs Market Overview

1.1 Product Overview and Scope of Gastroparesis Drugs

1.2 Classification of Gastroparesis Drugs by Types

1.2.1 Global Gastroparesis Drugs Revenue Comparison by Types (2017-2023)

1.2.2 Global Gastroparesis Drugs Revenue Market Share by Types in 2017

1.2.3 Prokinetic Agents

1.2.4 Antiemetic Agents

1.2.5 Botulinum Toxin Injection

1.2.6 Other

1.3 Global Gastroparesis Drugs Market by Application

1.3.1 Global Gastroparesis Drugs Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Diabetic Gastroparesis

1.3.3 Idiopathic Gastroparesis

1.4 Global Gastroparesis Drugs Market by Regions

1.4.1 Global Gastroparesis Drugs Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Gastroparesis Drugs Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Gastroparesis Drugs Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gastroparesis Drugs Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Gastroparesis Drugs Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gastroparesis Drugs Status and Prospect (2013-2023)

1.5 Global Market Size of Gastroparesis Drugs (2013-2023)

2 Manufacturers Profiles

2.1 Cadila Pharmaceuticals

2.1.1 Business Overview

2.1.2 Gastroparesis Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Cadila Pharmaceuticals Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.2 GlaxoSmithKline

2.2.1 Business Overview

2.2.2 Gastroparesis Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 GlaxoSmithKline Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.3 Johnson & Johnson

2.3.1 Business Overview

2.3.2 Gastroparesis Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Johnson & Johnson Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.4 Valeant

2.4.1 Business Overview

2.4.2 Gastroparesis Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Valeant Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.5 Evoke Pharma

2.5.1 Business Overview

2.5.2 Gastroparesis Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Evoke Pharma Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.6 Teva Pharmaceutical Industries

2.6.1 Business Overview

2.6.2 Gastroparesis Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Teva Pharmaceutical Industries Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.7 Theravance Biopharma

2.7.1 Business Overview

2.7.2 Gastroparesis Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Theravance Biopharma Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)

3 Global Gastroparesis Drugs Market Competition, by Players

3.1 Global Gastroparesis Drugs Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Gastroparesis Drugs Players Market Share

3.2.2 Top 10 Gastroparesis Drugs Players Market Share

3.3 Market Competition Trend

4 Global Gastroparesis Drugs Market Size by Regions

4.1 Global Gastroparesis Drugs Revenue and Market Share by Regions

4.2 North America Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

4.3 Europe Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

4.5 South America Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

5 North America Gastroparesis Drugs Revenue by Countries

5.1 North America Gastroparesis Drugs Revenue by Countries (2013-2018)

5.2 USA Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

5.3 Canada Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

5.4 Mexico Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

6 Europe Gastroparesis Drugs Revenue by Countries

6.1 Europe Gastroparesis Drugs Revenue by Countries (2013-2018)

6.2 Germany Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

6.3 UK Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

6.4 France Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

6.5 Russia Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

6.6 Italy Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Gastroparesis Drugs Revenue by Countries

7.1 Asia-Pacific Gastroparesis Drugs Revenue by Countries (2013-2018)

7.2 China Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

7.3 Japan Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

7.4 Korea Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

7.5 India Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

8 South America Gastroparesis Drugs Revenue by Countries

8.1 South America Gastroparesis Drugs Revenue by Countries (2013-2018)

8.2 Brazil Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

8.3 Argentina Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

8.4 Colombia Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Gastroparesis Drugs by Countries

9.1 Middle East and Africa Gastroparesis Drugs Revenue by Countries (2013-2018)

9.2 Saudi Arabia Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

9.3 UAE Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

9.4 Egypt Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

9.5 Nigeria Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

9.6 South Africa Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

10 Global Gastroparesis Drugs Market Segment by Type

10.1 Global Gastroparesis Drugs Revenue and Market Share by Type (2013-2018)

10.2 Global Gastroparesis Drugs Market Forecast by Type (2018-2023)

10.3 Prokinetic Agents Revenue Growth Rate (2013-2023)

10.4 Antiemetic Agents Revenue Growth Rate (2013-2023)

10.5 Botulinum Toxin Injection Revenue Growth Rate (2013-2023)

10.6 Other Revenue Growth Rate (2013-2023)

11 Global Gastroparesis Drugs Market Segment by Application

11.1 Global Gastroparesis Drugs Revenue Market Share by Application (2013-2018)

11.2 Gastroparesis Drugs Market Forecast by Application (2018-2023)

11.3 Diabetic Gastroparesis Revenue Growth (2013-2018)

11.4 Idiopathic Gastroparesis Revenue Growth (2013-2018)

12 Global Gastroparesis Drugs Market Size Forecast (2018-2023)

12.1 Global Gastroparesis Drugs Market Size Forecast (2018-2023)

12.2 Global Gastroparesis Drugs Market Forecast by Regions (2018-2023)

12.3 North America Gastroparesis Drugs Revenue Market Forecast (2018-2023)

12.4 Europe Gastroparesis Drugs Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Gastroparesis Drugs Revenue Market Forecast (2018-2023)

12.6 South America Gastroparesis Drugs Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Gastroparesis Drugs Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Gastroparesis Drugs Picture

Table Product Specifications of Gastroparesis Drugs

Table Global Gastroparesis Drugs and Revenue (Million USD) Market Split by Product Type

Figure Global Gastroparesis Drugs Revenue Market Share by Types in 2017

Figure Prokinetic Agents Picture

Figure Antiemetic Agents Picture

Figure Botulinum Toxin Injection Picture

Figure Other Picture

Table Global Gastroparesis Drugs Revenue (Million USD) by Application (2013-2023)

Figure Gastroparesis Drugs Revenue Market Share by Applications in 2017

Figure Diabetic Gastroparesis Picture

Figure Idiopathic Gastroparesis Picture

Table Global Market Gastroparesis Drugs Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Gastroparesis Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Gastroparesis Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Gastroparesis Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Gastroparesis Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Gastroparesis Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Gastroparesis Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Table Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Cadila Pharmaceuticals Gastroparesis Drugs Type and Applications

Table Cadila Pharmaceuticals Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Gastroparesis Drugs Type and Applications

Table GlaxoSmithKline Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Gastroparesis Drugs Type and Applications

Table Johnson & Johnson Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Valeant Basic Information, Manufacturing Base and Competitors

Table Valeant Gastroparesis Drugs Type and Applications

Table Valeant Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Evoke Pharma Basic Information, Manufacturing Base and Competitors

Table Evoke Pharma Gastroparesis Drugs Type and Applications

Table Evoke Pharma Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors

Table Teva Pharmaceutical Industries Gastroparesis Drugs Type and Applications

Table Teva Pharmaceutical Industries Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Theravance Biopharma Basic Information, Manufacturing Base and Competitors

Table Theravance Biopharma Gastroparesis Drugs Type and Applications

Table Theravance Biopharma Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Global Gastroparesis Drugs Revenue (Million USD) by Players (2013-2018)

Table Global Gastroparesis Drugs Revenue Share by Players (2013-2018)

Figure Global Gastroparesis Drugs Revenue Share by Players in 2016

Figure Global Gastroparesis Drugs Revenue Share by Players in 2017

Figure Global Top 5 Players Gastroparesis Drugs Revenue Market Share in 2017

Figure Global Top 10 Players Gastroparesis Drugs Revenue Market Share in 2017

Figure Global Gastroparesis Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Gastroparesis Drugs Revenue (Million USD) by Regions (2013-2018)

Table Global Gastroparesis Drugs Revenue Market Share by Regions (2013-2018)

Figure Global Gastroparesis Drugs Revenue Market Share by Regions (2013-2018)

Figure Global Gastroparesis Drugs Revenue Market Share by Regions in 2017

Figure North America Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure Europe Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure South America Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Table North America Gastroparesis Drugs Revenue by Countries (2013-2018)

Table North America Gastroparesis Drugs Revenue Market Share by Countries (2013-2018)

Figure North America Gastroparesis Drugs Revenue Market Share by Countries (2013-2018)

Figure North America Gastroparesis Drugs Revenue Market Share by Countries in 2017

Figure USA Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure Canada Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure Mexico Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Table Europe Gastroparesis Drugs Revenue (Million USD) by Countries (2013-2018)

Figure Europe Gastroparesis Drugs Revenue Market Share by Countries (2013-2018)

Figure Europe Gastroparesis Drugs Revenue Market Share by Countries in 2017

Figure Germany Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure UK Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure France Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure Russia Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure Italy Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Gastroparesis Drugs Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Gastroparesis Drugs Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Gastroparesis Drugs Revenue Market Share by Countries in 2017

Figure China Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure Japan Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure Korea Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure India Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Table South America Gastroparesis Drugs Revenue by Countries (2013-2018)

Table South America Gastroparesis Drugs Revenue Market Share by Countries (2013-2018)

Figure South America Gastroparesis Drugs Revenue Market Share by Countries (2013-2018)

Figure South America Gastroparesis Drugs Revenue Market Share by Countries in 2017

Figure Brazil Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure Argentina Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure Colombia Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Gastroparesis Drugs Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Gastroparesis Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Gastroparesis Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Gastroparesis Drugs Revenue Market Share by Countries in 2017

Figure Saudi Arabia Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure UAE Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure Egypt Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure Nigeria Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Figure South Africa Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

Table Global Gastroparesis Drugs Revenue (Million USD) by Type (2013-2018)

Table Global Gastroparesis Drugs Revenue Share by Type (2013-2018)

Figure Global Gastroparesis Drugs Revenue Share by Type (2013-2018)

Figure Global Gastroparesis Drugs Revenue Share by Type in 2017

Table Global Gastroparesis Drugs Revenue Forecast by Type (2018-2023)

Figure Global Gastroparesis Drugs Market Share Forecast by Type (2018-2023)

Figure Global Prokinetic Agents Revenue Growth Rate (2013-2018)

Figure Global Antiemetic Agents Revenue Growth Rate (2013-2018)

Figure Global Botulinum Toxin Injection Revenue Growth Rate (2013-2018)

Figure Global Other Revenue Growth Rate (2013-2018)

Table Global Gastroparesis Drugs Revenue by Application (2013-2018)

Table Global Gastroparesis Drugs Revenue Share by Application (2013-2018)

Figure Global Gastroparesis Drugs Revenue Share by Application (2013-2018)

Figure Global Gastroparesis Drugs Revenue Share by Application in 2017

Table Global Gastroparesis Drugs Revenue Forecast by Application (2018-2023)

Figure Global Gastroparesis Drugs Market Share Forecast by Application (2018-2023)

Figure Global Diabetic Gastroparesis Revenue Growth Rate (2013-2018)

Figure Global Idiopathic Gastroparesis Revenue Growth Rate (2013-2018)

Figure Global Gastroparesis Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Gastroparesis Drugs Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Gastroparesis Drugs Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Gastroparesis Drugs Revenue Market Forecast (2018-2023)

Figure Europe Gastroparesis Drugs Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Gastroparesis Drugs Revenue Market Forecast (2018-2023)

Figure South America Gastroparesis Drugs Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Gastroparesis Drugs Revenue Market Forecast (2018-2023)



【レポートのキーワード】

胃不全麻痺薬、消化管機能改善薬、制吐剤、ボツリヌス毒素注射、その他、糖尿病性胃不全麻痺、特発性胃不全麻痺

★調査レポート[胃不全麻痺薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8102688)販売に関する免責事項を必ずご確認ください。
★調査レポート[胃不全麻痺薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆